{"entity":{"type":"insider","cik":"0001355850","url":"/insider/0001355850","json_url":"/insider/0001355850.json","name":"Eramian Daniel G","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":5,"first":"2009-09-25","last":"2012-09-21","span_basis":"filed_date"},"name_variants":[{"name":"Eramian Daniel G","source":"filing","n_filings":5,"first_seen":"2009-09-25","last_seen":"2012-09-21"}],"transactions":[{"id":2938173,"accession":"0000891293-12-000053","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000891293-12-000053","line_url":"/filing/0000891293-12-000053#line-1","is_derivative":false,"issuer_cik":"0000891293","issuer_name":"CELL THERAPEUTICS INC","issuer_ticker":"CTIC","issuer_name_source":null,"issuer_url":"/issuer/0000891293","owner_cik":"0001355850","owner_name":"Eramian Daniel G","owner_display_name":"Eramian Daniel G","owner_url":"/insider/0001355850","role":"Officer (EVP, Corporate Communications)","role_mark":"O","role_mark_label":"Officer (EVP, Corporate Communications)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corporate Communications","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":2.68,"price_display":"2.68","price_state":"stated","total_value":40200.0,"total_display":"40,200.00","total_whole":"40,200","shares_owned_after":354350.0,"shares_owned_after_display":"354,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-09-20","filed_date":"2012-09-21","scope":"insider"},{"id":3209989,"accession":"0000891293-12-000049","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000891293-12-000049","line_url":"/filing/0000891293-12-000049","is_derivative":false,"issuer_cik":"0000891293","issuer_name":"CELL THERAPEUTICS INC","issuer_ticker":"CTIC","issuer_name_source":null,"issuer_url":"/issuer/0000891293","owner_cik":"0001355850","owner_name":"Eramian Daniel G","owner_display_name":"Eramian Daniel G","owner_url":"/insider/0001355850","role":"Officer (EVP, Corporate Communications)","role_mark":"O","role_mark_label":"Officer (EVP, Corporate Communications)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corporate Communications","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":95000.0,"shares_display":"95,000","price_per_share":0.39172044210526313,"price_display":"0.39","price_state":"stated","total_value":37213.442,"total_display":"37,213.44","total_whole":"37,213","shares_owned_after":1900203.0,"shares_owned_after_display":"1,900,203","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-24","filed_date":"2012-08-24","scope":"insider","n_lines":4},{"id":2180644,"accession":"0000891293-12-000040","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000891293-12-000040","line_url":"/filing/0000891293-12-000040","is_derivative":false,"issuer_cik":"0000891293","issuer_name":"CELL THERAPEUTICS INC","issuer_ticker":"CTIC","issuer_name_source":null,"issuer_url":"/issuer/0000891293","owner_cik":"0001355850","owner_name":"Eramian Daniel G","owner_display_name":"Eramian Daniel G","owner_url":"/insider/0001355850","role":"Officer (EVP, Corporate Communications)","role_mark":"O","role_mark_label":"Officer (EVP, Corporate Communications)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corporate Communications","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":0.57528138,"price_display":"0.58","price_state":"stated","total_value":28764.069,"total_display":"28,764.07","total_whole":"28,764","shares_owned_after":1941761.0,"shares_owned_after_display":"1,941,761","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-28","filed_date":"2012-06-29","scope":"insider","n_lines":7},{"id":7536894,"accession":"0000891293-10-000051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000891293-10-000051","line_url":"/filing/0000891293-10-000051#line-1","is_derivative":false,"issuer_cik":"0000891293","issuer_name":"CELL THERAPEUTICS INC","issuer_ticker":"CTIC","issuer_name_source":null,"issuer_url":"/issuer/0000891293","owner_cik":"0001355850","owner_name":"Eramian Daniel G","owner_display_name":"Eramian Daniel G","owner_url":"/insider/0001355850","role":"Officer (EVP, Corporate Communications)","role_mark":"O","role_mark_label":"Officer (EVP, Corporate Communications)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corporate Communications","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250000.0,"shares_display":"250,000","price_per_share":0.36,"price_display":"0.36","price_state":"stated","total_value":90000.0,"total_display":"90,000.00","total_whole":"90,000","shares_owned_after":4424899.0,"shares_owned_after_display":"4,424,899","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-16","filed_date":"2010-12-17","scope":"insider"},{"id":5723090,"accession":"0000891293-09-000035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000891293-09-000035","line_url":"/filing/0000891293-09-000035#line-1","is_derivative":false,"issuer_cik":"0000891293","issuer_name":"CELL THERAPEUTICS INC","issuer_ticker":"CTIC","issuer_name_source":null,"issuer_url":"/issuer/0000891293","owner_cik":"0001355850","owner_name":"Eramian Daniel G","owner_display_name":"Eramian Daniel G","owner_url":"/insider/0001355850","role":"Officer (EVP, Corporate Communications)","role_mark":"O","role_mark_label":"Officer (EVP, Corporate Communications)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Corporate Communications","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":104276.0,"shares_display":"104,276","price_per_share":1.25,"price_display":"1.25","price_state":"stated","total_value":130345.0,"total_display":"130,345.00","total_whole":"130,345","shares_owned_after":1269955.0,"shares_owned_after_display":"1,269,955","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-25","filed_date":"2009-09-25","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000891293","name":"CELL THERAPEUTICS INC","url":"/issuer/0000891293","role":"Officer (EVP, Corporate Communications)","n_filings":5,"first_seen":"2009-09-25","last_seen":"2012-09-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001355850","retrieved_at":"2026-08-23T01:29:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}